abrdn Life Sciences Investors - Common (HQL)

CUSIP: 87911K100

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common
Shares outstanding
29,948,325
Total 13F shares
9,135,304
Share change
-47,626
Total reported value
$141,452,290
Price per share
$15.51
Number of holders
82
Value change
-$612,075
Number of buys
45
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q3 2025

As of 30 Sep 2025, abrdn Life Sciences Investors - Common (HQL) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,135,304 shares. The largest 10 holders included Saba Capital Management, L.P., MORGAN STANLEY, Penserra Capital Management LLC, RAYMOND JAMES FINANCIAL INC, NEEDHAM INVESTMENT MANAGEMENT LLC, LPL Financial LLC, FLAGSHIP HARBOR ADVISORS, LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, Karpus Management, Inc., and Allspring Global Investments Holdings, LLC. This page lists 82 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.